1Morris PL, Robinson RG, Andrzejewski P, et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry, 1993,150(1): 124-129.
2King RB. Quality of life after stroke. Stroke, 1996, 27 (9): 1467-1472.
3Lofgren B, Gustafson Y, Nyberg L. Psychological well-being 3 years after severe stroke. Stroke, 1999, 30(3): 567-572.
4Gordon WA, Hibard MR. Poststroke depression: an examination of the literature. Arch Phys Med Rehabil, 1997, 78(6): 658-663.
5Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial.Stroke, 2000, 31 (7): 1482-1486.
6Andersen G, Vestergaard K, Lauritzen L Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 1994, 25(6): 1099-1104.
7Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000, 31(8): 1829-1832.
8Lane RM, Sweeney M, Henry JA. Pharmacotherapy of the depressed patient with cardiovascular and/or cerebrovascular illness.Br J C1in Pract., 1994, 48(5): 256-262.
9Palomaki H, Kaste M, Berg A, et al. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy. J Neurol Neurosurg Psychiatry, 1999, 66(4): 490-494.
10Crott R, Gilis P. Economic comparisons of the pharmacotherapy of depression: an overview. Acta Psychiatr Scand, 1998, 97(4): 241-252.
